| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 93.905 | 68.337 | 65.749 | 29.747 | 18.080 | 0 | 0 | 0 | 0 | 1.383.407 |
| Total Income - EUR | 102.228 | 73.702 | 120.929 | 29.985 | 23.167 | 6 | 0 | 4.276 | 0 | 1.384.723 |
| Total Expenses - EUR | 98.450 | 97.527 | 70.726 | 32.027 | 16.935 | 288 | 916 | 20.074 | 22.719 | 569.742 |
| Gross Profit/Loss - EUR | 3.778 | -23.826 | 50.203 | -2.041 | 6.232 | -282 | -916 | -15.798 | -22.719 | 814.980 |
| Net Profit/Loss - EUR | 2.327 | -24.509 | 48.723 | -2.339 | 5.702 | -282 | -916 | -15.841 | -22.719 | 687.764 |
| Employees | 4 | 4 | 1 | 1 | 1 | 0 | 0 | 2 | 2 | 4 |
Check the financial reports for the company - Top-Pharma Marketing S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 23.057 | 16.921 | 5.083 | 3.058 | 2.857 | 2.803 | 2.741 | 2.056 | 2.050 | 725 |
| Current Assets | 98.854 | 88.451 | 52.083 | 46.326 | 21.796 | 20.995 | 19.613 | 9.061 | 9.778 | 1.095.668 |
| Inventories | 20.000 | 33.862 | 2.678 | 9.239 | 90 | 89 | 87 | 87 | 0 | 0 |
| Receivables | 69.087 | 42.794 | 29.380 | 24.733 | 11.512 | 8.673 | 7.773 | 8.454 | 8.675 | 687.679 |
| Cash | 9.767 | 11.795 | 20.025 | 12.353 | 10.194 | 12.234 | 11.753 | 519 | 1.103 | 407.989 |
| Shareholders Funds | -7.751 | -32.312 | 16.958 | 14.343 | 19.767 | 19.110 | 17.770 | 1.985 | -21.302 | 666.581 |
| Social Capital | 450 | 445 | 438 | 430 | 421 | 413 | 404 | 406 | 404 | 402 |
| Debts | 130.029 | 138.042 | 40.322 | 35.081 | 4.885 | 4.688 | 4.584 | 9.132 | 33.130 | 429.812 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Top-Pharma Marketing S.r.l.